In 1982, Dr. David S. Boyer helped co-pioneer the formation of the Retina Vitreous Associates Medical Group in Los Angeles, CA. Now, with eight other doctors (Dr. Roger L. Novack, Dr. Thomas G. Chu, Dr. Firas M. Rahhal, Dr. Homayoun Tabandeh, Dr. Richard Roe, Dr. Pouya N. Dayani, Dr. David Liao, and Dr. Alexander Walsh) and five other locations in Beverly Hills (1987), in the San Fernando Valley (1994), in the South Bay area (1998), in the Santa Clarita Valley (2006), and the San Gabriel Valley (2011), Retina Vitreous Associates Medical Group has become a nationally recognized leader and continues to serve communities in Southern California. The group specializes in the treatment of diseases affecting the retina, the vitreous and the macula, including macular degeneration, diabetic retinopathy, retinal detachment, retinitis, uveitis, ocular tumors and pediatric retinal diseases. Retina-Vitreous Associates Medical Group houses state of the art diagnostic equipment and treatment facilities, including a visual function laboratory that offers full service electrophysiology testing. The physicians at Retina-Vitreous Associates Medical Group are leaders and participate in most clinical trials assessing new therapies for macular degeneration, diabetic retinopathy, and other retinal diseases. Retina-Vitreous Associates Medical Group has one of only two noncontact widefield fluorescein angiography units available in California. Our physicians are widely published, including journal articles and books, and are invited to lectures all over the world. In addition to its clinical services, Retina-Vitreous Associates Medical Group provides continuing education and consulting services to the local, national and international ophthalmic communities and other healthcare industries.
Each doctor in our group is board certified in ophthalmology and has completed formal subspecialty training in medical and surgical diseases of the retina, vitreous and macula. Each member is nationally recognized for their participation in research and educational programs primarily aimed at understanding the causes of retinal diseases and developing novel treatments. For each of our esteemed Doctors, a brief biographical sketch is provided.